Scroll Top

Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia

Precision Medicine Online

Sep 15 2023

June 10, 2026

https://www.labiotech.eu/in-depth/neurology-technology/

June 9, 2026

https://european-biotechnology.com/latest-news/bial-drops-pariceract-after-phase-iib-failure-in-gba-associated-parkinsons/

May 27, 2026

https://finance.yahoo.com/sectors/healthcare/articles/gain-therapeutics-expands-compelling-evidence-043446986.html